CB1 antagonist 4 (compound 8) is a peripheral selective cannabinoid receptor type 1 ( CB1 ) receptor antagonist. CB1 antagonist 4 shows limited penetrance to the brain in order to minimize or prevent CNS adverse reactions, and preserves potential antiobesity effects. CB1 antagonist 4 reduces propensity for psychiatric side effects .